CAS No. |
2417370-49-9 |
|---|---|
中文名称 |
S-(3-((((((3R,5S)-1-((S)-15-叔丁基-1-(4-(3,5-二氟吡啶-2-基)-10-甲基-7-((甲基磺酰基)甲基)-11-氧代-3,4,10,11-四氢-1H-1,4,10-三氮杂二苯并[cd,f]氮杂䓬-6-基)-1,13-二氧代-5,8,11-三氧杂-2,14-二氮杂十六烷-16-酰基)-5-((4-(4-甲基噻唑-5-基)苄基)氨基甲酰基)吡咯烷-3-基)氧基)羰基)氧基)丁-2-基)甲磺酰硫代酯 |
英文名称 |
S-(3-(((((3R,5S)-1-((S)-15-(tert-Butyl)-1-(4-(3,5-difluoropyridin-2-yl)-10-methyl-7-((methylsulfonyl)methyl)-11-oxo-3,4,10,11-tetrahydro-1H-1,4,10-triazadibenzo[cd,f]azulen-6-yl)-1,13-dioxo-5,8,11-trioxa-2,14-diazahexadecan-16-oyl)-5-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-3-yl)oxy)carbonyl)oxy)butan-2-yl) methanesulfonothioate |
别名 |
PROTAC BRD4 Degrader-10 |
标准英文名 |
S-(3-(((((3R,5S)-1-((S)-15-(tert-butyl)-1-(4-(3,5-difluoropyridin-2-yl)-10-methyl-7-((methylsulfonyl)methyl)-11-oxo-3,4,10,11-tetrahydro-1H-1,4,10-triazadibenzo[cd,f]azulen-6-yl)-1,13-dioxo-5,8,11-trioxa-2,14-diazahexadecan-16-oyl)-5-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-3-yl)oxy)carbonyl)oxy)butan-2-yl) methanesulfonothioate |
分子式 |
C59H71F2N9O15S4 |
分子量 |
1312.53 |
精确分子量 |
1311.39 |
SMILES |
O=C1C2=C3C(C=4C(N(CC3=CN2)C5=C(F)C=C(F)C=N5)=CC(C(NCCOCCOCCOCC(N[C@H](C(=O)N6[C@H](C(NCC7=CC=C(C=C7)C=8SC=NC8C)=O)C[C@@H](OC(OC(C(SS(C)(=O)=O)C)C)=O)C6)C(C)(C)C)=O)=O)=C(CS(C)(=O)=O)C4)=CN1C |
标准SMILES |
CN1C=C2C3=C(NC=C3CN(C3N=CC(F)=CC=3F)C3=CC(=C(CS(C)(=O)=O)C=C32)C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@@H](C[C@H]2C(=O)NCC2C=CC(=CC=2)C2SC=NC=2C)OC(=O)OC(C)C(C)SS(C)(=O)=O)C(C)(C)C)C1=O |
用途 |
PROTAC BRD4 Degrader-10 can be conjugated with STEAP1 and CLL1 antibodies to degrade BRD4 protein in PC3 prostate cancer cells, with DC50 values of 1.3 nM and 18 nM, respectively. |
InChIKey |
FUFQNGIGEJGHCG-YDIRMPGESA-N |
|
|
评论 |
|---|